Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

New England Journal of Medicine

Volumn 348, Issue 26, 2003, Pages 2618-2625

  Aaron, Shawn D ^a,g   Vandemheen, Katherine L ^b   Hebert, Paul ^a   Dales, Robert ^a   Stiell, Ian G ^a   Ahuja, Jan ^a   Dickinson, Garth ^a   Brison, Robert ^c   Rowe, Brian H ^d   Dreyer, Jonathan ^e   Yetisir, Elizabeth ^b   Cass, Daniel ^f   Wells, George ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; GLUCOSE; PLACEBO; PREDNISONE;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EMERGENCY TREATMENT; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ACUTE DISEASE; ADMINISTRATION, ORAL; AGED; AMBULATORY CARE; DOUBLE-BLIND METHOD; EMERGENCY TREATMENT; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 0037832413     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa023161     Document Type: Article

References (23)

1. Sin DD, Bell NR, Svenson LW, Man SF. The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med 2002;112:120-5.
2. Lau AC, Yam LY, Poon E. Hospital readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2001;95:876-84.
3. Murata GH, Gorby MS, Kapsner CO, Chick TW, Halperin AK. A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease. Arch Intern Med 1992;152:73-7.
4. Stehr DE, Klein BJ, Murata GH. Emergency department return visits in chronic obstructive pulmonary disease: the importance of psychosocial factors. Ann Emerg Med 1991;20:1113-6.
5. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999;354:456-60.
6. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340:1941-7.
7. Wood-Baker RWB, Walters EH, Gibson PG. Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2001;2: CD001288.
8. McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD: a critical review. Chest 1997;111:732-43.
9. Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000;355:542-5.
10. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12.
11. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
12. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:Suppl 5: S1-S28.
13. Chapman KR, Verbeek PR, White JG, Rebuck AS. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med 1991;324:788-94.
14. Standardization of spirometry - 1987 update: statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
15. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-8.
16. Redelmeier DA, Goldstein RS, Min ST, Hyland RH. Spirometry and dyspnea in patients with COPD: when small differences mean little. Chest 1996;109:1163-8.
17. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002;121:688-96.
18. Miravitlles M, Murio C, Guerrero T, Gisbert R. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449-55.
19. Rowe B, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2001;1:CD000195.
20. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
21. Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-13.
22. Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67-71.
23. McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:704-9.